Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Evaluation of the validity of Hb A2 and mean corpuscular haemoglobin action values in antenatal screening for beta thalassaemia carriers in England.

British journal of haematology - 1 Aug 2014

Daniel Yvonne, Cartwright Ronwyn, Rennie Kristian, Streetly Allison, Howard Jo

Abstract excerpt

National antenatal screening of all pregnant women in England is carried out using standards and guidelines produced by the National Health Service Sickle Cell and Thalassaemia Screening Programme. The algorithms for detection of beta thalassaemia carrier status rely on action criteria, which are set using the percentage Hb A2 and mean corpuscular haemoglobin (MCH) values. Three groups of samples: MCH <27 pg and...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to beta-Thalassemia
Share to Chromatography, High Pressure Liquid

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Erythrocyte Indices

Share to Genetic Carrier Screening

Share to Genetic Testing

Share to Hemoglobin A2

Share to Pregnancy

Share to Prenatal Diagnosis

Source

Identifiers

PMID: 24754789
DOI: 10.1111/bjh.12917

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 8 closest

Evaluation of the validity of Hb A2 and mean corpuscular haemoglobin action values in antenatal screening for beta thalassaemia carriers in England.PMID 24754789Read ↗

Thalassaemia screening in pregnancySemantic proximity Read ↗

Variation in Antenatal Anaemia Guidelines Across the NHS in the UK: A Descriptive Cross-Sectional Study.Semantic proximity Read ↗

Comparison of Masimo Total Hemoglobin SpHb® continuous non-invasive hemoglobin monitoring device with laboratory complete blood count measurement using venous sample: Protocol for an observational substudy of the Pregnancy Risk and Infant Surveillance and Measurement Alliance Maternal and Newborn Health (PRISMA MNH) studySemantic proximity Read ↗

Sickle cell disease and thalassaemia antenatal screening programme in England over 10 years: a review from 2007/2008 to 2016/2017Semantic proximity Read ↗

EMQN Best Practice Guidelines for molecular and haematology methods for carrier identification and prenatal diagnosis of the haemoglobinopathies.Semantic proximity Read ↗

Laboratory parameters provided by Advia 2120 analyser identify structural haemoglobinopathy carriers and discriminate between Hb S trait and Hb C trait.Semantic proximity Read ↗

Statistical haemoglobin thresholds to define anaemia across the lifecycleSemantic proximity Read ↗

Clinical experience using peripheral blood parameters to analyse the mutation type of thalassemia carriers in pregnant women.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.